MedTrace Logo

The Effects of Losartan on Reward Reinforcement Learning

NCT04604938 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-10-27

No results posted yet for this study

Summary

This study aims to investigate whether a single dose of losartan (50 mg) can affect learning from positive and negative outcomes and its related neural mechanisms.

Conditions

  • Healthy

Interventions

DRUG

Losartan

administration of losartan (50 mg) (oral)

DRUG

Placebo oral tablet

administration of placebo (oral)

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Benjamin Becker, PhD · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2021-12-31
Completion
2022-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04604938 on ClinicalTrials.gov